These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11532384)

  • 1. Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient.
    Su KP; Shen WW; Huang SY
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):295-9. PubMed ID: 11532384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
    Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
    BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
    Hsu MC; Huang YS; Ouyang WC
    Lipids Health Dis; 2020 Jul; 19(1):159. PubMed ID: 32620164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
    J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia.
    Peet M
    Isr J Psychiatry Relat Sci; 2008; 45(1):19-25. PubMed ID: 18587166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids in psychiatry: a review.
    Freeman MP
    Ann Clin Psychiatry; 2000 Sep; 12(3):159-65. PubMed ID: 10984006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.
    Emsley R; Oosthuizen P; van Rensburg SJ
    CNS Drugs; 2003; 17(15):1081-91. PubMed ID: 14661986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of omega-3 Fatty acids for prevention or treatment of perinatal depression.
    Borja-Hart NL; Marino J
    Pharmacotherapy; 2010 Feb; 30(2):210-6. PubMed ID: 20099994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
    Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
    Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
    Schlögelhofer M; Amminger GP; Schaefer MR; Fusar-Poli P; Smesny S; McGorry P; Berger G; Mossaheb N
    Early Interv Psychiatry; 2014 Aug; 8(3):199-208. PubMed ID: 24861004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy.
    Freeman MP; Cohen LS; McInerney K
    J Clin Psychopharmacol; 2014 Oct; 34(5):627-32. PubMed ID: 25006815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
    Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
    Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.
    Amminger GP; Schäfer MR; Schlögelhofer M; Klier CM; McGorry PD
    Nat Commun; 2015 Aug; 6():7934. PubMed ID: 26263244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study.
    Nishi D; Su KP; Usuda K; Chang JP; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Hashimoto K; Hamazaki T; Matsuoka YJ
    Nutr Neurosci; 2019 Jan; 22(1):63-71. PubMed ID: 28752805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and safety of antipsychotic drugs during pregnancy.
    Einarson A; Boskovic R
    J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects.
    Chen AT; Chibnall JT; Nasrallah HA
    Ann Clin Psychiatry; 2015 Nov; 27(4):289-96. PubMed ID: 26554370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study.
    Kim SW; Jhon M; Kim JM; Smesny S; Rice S; Berk M; Klier CM; McGorry PD; Schäfer MR; Amminger GP
    PLoS One; 2016; 11(3):e0151417. PubMed ID: 26963912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.